What are Eton Pharmaceuticals, Inc.'s profit margins?

Eton Pharmaceuticals, Inc. (ETON) runs a 54.8% gross margin and a -15.1% operating margin, with a -9.5% net margin.

Where do Eton Pharmaceuticals, Inc.'s ratios come from?

Every ratio is computed from Eton Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Eton Pharmaceuticals, Inc. ETON Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	53.5%-6.6pp	60%-6.5pp	66.6%-0.8pp	67.4%-19.8pp
Efficiency
Asset turnover	1×+0.2×	0.7×-0.4×	1.1×+0.3×	0.8×0.0×
Inventory turnover	2.4×+0.5×	1.9×-12.5×	14.4×+1.9×	12.5×+9.4×
Liquidity
Current ratio	1.6×-0.5×	2.1×+0.4×	1.7×-1.4×	3.1×-2.1×
Quick ratio	1.2×-0.1×	1.3×-0.3×	1.6×-1.4×	3×-2.0×
Cash ratio	0.7×-0.1×	0.7×-0.6×	1.3×-1.2×	2.5×-0.6×
Leverage
Debt-to-equity	1.2×0.0×	1.2×+0.9×	0.4×-0.2×	0.5×+0.1×
Debt-to-assets	0.3×-0.1×	0.4×+0.2×	0.2×-0.1×	0.3×0.0×
Valuation
Market capitalization	$930.79M+162%	$347.01M+209%	$112.38M+57.5%	$71.34M-32.4%
Enterprise value	$942.39M+156%	$362.06M+275%	$96.45M+56.5%	$61.64M-37.0%
Price / sales	10.7×+3.4×	8.9×+5.3×	3.6×+0.2×	3.4×-1.5×
Price / book	31.2×+16.3×	14.2×+6.9×	7.3×+1.8×	5.5×-0.5×
EV / sales	11.1×+3.3×	9.3×+6.2×	3×+0.1×	2.9×-1.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Eton Pharmaceuticals, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Eton Pharmaceuticals, Inc.'s profit margins?: Eton Pharmaceuticals, Inc. (ETON) runs a 54.8% gross margin and a -15.1% operating margin, with a -9.5% net margin.
Where do Eton Pharmaceuticals, Inc.'s ratios come from?: Every ratio is computed from Eton Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.